Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: Evidence from a systematic review of 22 case-control studies

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Yang, Yongzhi ^a,b   Wang, Feng ^a   Shi, Chenzhang ^b   Zou, Yang ^b   Qin, Huanlong ^a   Ma, Yanlei ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CCND1 PROTEIN, HUMAN;

ALLELE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CCND1 GENE; COLORECTAL CANCER; DISEASE ASSOCIATION; ETHNICITY; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SYSTEMATIC REVIEW; CAUCASIAN; COLORECTAL TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; PROTO ONCOGENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLIN D1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, BCL-1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84860992315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036813     Document Type: Review

References (53)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Ferlay J, Parkin DM, Steliarova-Foucher E, (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
4. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047.
5. Markowitz SD, Bertagnolli MM, (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
6. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES, (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628.
7. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, et al. (2008) Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17: 2773-2781.
8. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
10. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
11. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
12. Galbraith RF, (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7: 889-894.
13. Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, et al. (2009) More than numbers: the power of graphs in meta-analysis. Am J Epidemiol 169: 249-255.
14. L'Abbe KA, Detsky AS, O'Rourke K, (1987) Meta-analysis in clinical research. Ann Intern Med 107: 224-233.
15. Song F, (1999) Exploring heterogeneity in meta-analysis: is the L'Abbe plot useful? J Clin Epidemiol 52: 725-730.
16. Haber M, (1981) Exact significance levels of goodness-of-fit tests for the Hardy-Weinberg equilibrium. Hum Hered 31: 161-166.
17. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
18. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
19. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37: 120-132.
20. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, et al. (2000) Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 60: 249-252.
21. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, et al. (2000) Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer 88: 77-81.
22. Bala S, Peltomaki P, (2001) CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61: 6042-6045.
23. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, et al. (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93: 1106-1108.
24. Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, et al. (2002) Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21: 1928-1933.
25. Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B, (2003) Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 23: 4257-4259.
26. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR, (2003) Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290: 2843-2848.
27. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, et al. (2003) Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63: 8549-8553.
28. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY, (2005) GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 41: 1037-1044.
29. Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, et al. (2006) Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 49: 602-608.
30. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, et al. (2006) Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 132: 193-199.
31. Kruger S, Engel C, Bier A, Mangold E, Pagenstecher C, et al. (2006) Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 236: 191-197.
32. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, et al. (2006) The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 27: 2475-2482.
33. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, et al. (2006) Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 94: 928-934.
34. Forones NM, de Lima JM, de Souza LG, da Silva ID, (2008) Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J Gastrointest Cancer 39: 118-123.
35. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, et al. (2008) Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23: 147-154.
36. Talseth BA, Ashton KA, Meldrum C, Suchy J, Kurzawski G, et al. (2008) Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 122: 1273-1277.
37. Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, et al. (2008) The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 122: 2573-2580.
38. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, et al. (2010) Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet 51: 343-352.
39. Kanaan Z, Eichenberger MR, Young M, Colliver D, Crawford N, et al. (2010) An alternative cyclin-D1 splice site is not linked to inflammatory bowel disease-associated neoplasia. Int J Biol Markers 25: 27-31.
40. Liu B, Zhang Y, Jin M, Ni Q, Liang X, et al. (2010) Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog 49: 75-84.
41. Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, et al. (2010) The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 30: 2875-2880.
42. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
43. Evan GI, Vousden KH, (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348.
44. Ekholm SV, Reed SI, (2000) Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12: 676-684.
45. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, et al. (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011.
46. Lu F, Gladden AB, Diehl JA, (2003) An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 63: 7056-7061.
47. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, et al. (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278: 30339-30347.
48. Gerard C, Goldbeter A, (2009) Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc Natl Acad Sci U S A 106: 21643-21648.
49. Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, et al. (2006) Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev Cell 10: 563-573.
50. Chen B, Cao L, Yang P, Zhou Y, Wu XT, (2011) Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: A meta-analysis comprising 20,271 subjects. Cancer Epidemiol.
51. Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, et al. (2009) Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res 15: 5338-5349.
52. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, et al. (2001) Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159: 1917-1924.
53. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, et al. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43: 1108-1113.